DGX - Quest Diagnostics Incorporated logo

DGX

Quest Diagnostics Incorporated

Quest Diagnostics provides diagnostic testing and services, including clinical and anatomic pathology testing, to physicians, hospitals, and consumers. It operates a network of laboratories and patient service centers, offering various health solutions.

โš•๏ธ Healthcare NYSE Listed 1996 $ USD
$1,000 invested 20 years ago โ†’$5,389today

Score Overview

1 Year
Score
Net Growth7.06%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth4.76%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score5.3
Net Growth-46.77%
Net Trend60%
Net Income Consistencyโ€”
Rev Growth7.16%
Rev Trend60%
Revenue Consistencyโ€”
10 Years
Score
Net Growth64.65%
Net Trend70%
Net Income Consistency
Rev Growth53.83%
Rev Trend70%
Revenue Consistency
20 Years
Score5.7
Net Growth81.10%
Net Trend60%
Net Income Consistency
Rev Growth84.41%
Rev Trend70%
Revenue Consistency
All Time
Score
Net Growth269.66%
Net Trend70%
Net Income Consistency
Rev Growth7x
Rev Trend73%
Revenue Consistency

See the full market ranking โ†’

Quest Diagnostics Incorporated fundamental performance

Between 2005 and 2025, revenue grew from $ 5.50B to $ 11.03B and net income grew from $ 546M to $ 992M. Revenue increased in 14 of those 20 years; net income in 12.

Across Quest Diagnostics Incorporated's full reported history, from 1996 to 2025, revenue grew from $ 1.61B to $ 11.03B and net income went from -$ 625M to $ 992M. Revenue increased in 73% of the years measured; net income in 70%.

Quest Diagnostics Incorporated currently holds a 20-year HDB Score of 5.7 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 237.77โ€”
1 Year2025-08-12
$ 175.6035.40%
5 Years2021-08-12
$ 133.7277.81%
10 Years2016-08-12
$ 70.06239.36%
20 Years2006-08-11
$ 44.12438.86%
All Time1996-12-17
$ 2.4696x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 11.56B$ 1.06B$ 626M
2025$ 11.03B$ 992M$ 420M
2024$ 9.87B$ 871M$ 549M
2023$ 9.25B$ 854M$ 686M
2022$ 9.88B$ 946M$ 315M
2021$ 10.78B$ 1.99B$ 872M
2020$ 9.43B$ 1.43B$ 1.15B
2019$ 7.72B$ 858M$ 1.19B
2018$ 7.53B$ 736M$ 135M
2017$ 7.70B$ 772M$ 137M
2016$ 7.51B$ 645M$ 359M
2015$ 7.49B$ 709M$ 133M
2014$ 7.43B$ 556M$ 192M
2013$ 7.14B$ 849M$ 187M
2012$ 7.38B$ 555M$ 295M
2011$ 7.51B$ 470M$ 164M
2010$ 7.36B$ 720M$ 449M
2009$ 7.45B$ 729M$ 534M
2008$ 7.24B$ 581M$ 253M
2007$ 6.70B$ 339M$ 167M
2006$ 6.26B$ 586M$ 149M
2005$ 5.50B$ 546M$ 92M
2004$ 5.12B$ 499M$ 73M
2003$ 4.73B$ 436M$ 154M
2002$ 4.10B$ 322M$ 96M
2001$ 3.62B$ 162M$ 122M
2000$ 3.42B$ 102M$ 171M
1999$ 2.20B-$ 3M$ 27M
1998$ 1.45B$ 26M$ 202M
1997$ 1.52B-$ 22M$ 161M
IPO1996$ 1.61B-$ 625M$ 41M

Explore beyond DGX

You're looking at Quest Diagnostics Incorporated. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies